ESSA Contact Information: David Wood Chief Financial Officer, ESSA Pharma Inc. T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] ...

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously ...

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously ...

ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously announced business combination agreement with XenoTherapeutics, Inc. ("Xeno"), a ...

ESSA Contact Information: David Wood Chief Financial Officer, ESSA Pharma Inc. T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] SOURCE ESSA Pharma Inc.

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders Newswire.ca - Wed Jul 23, 3:51PM CDT ...